Trelegy Ellipta is the second 3-in-1 treatment for...
The obesity treatment naltrexone/bupropion (Mysimba)...
Prescribers can now consult a handy MIMS table to check...
NICE suggests offering a leukotriene receptor antagonist...
Dupilumab (Dupixent) is the first biologic treatment...
New and deleted products
Instructions for changing or stopping antidepressants.
Summary of NICE guidance on Helicobacter treatment.
Hormone doses and costs of HRT preparations.
Compatibility of drugs mixed in a syringe driver.
Guide to potencies of opioid analgesics, for dose conversion.
Featured MIMS resources
New products coming soon to MIMS
Check back soon to find MIMS listings for the following new drugs:
Fertavid (follitropin beta)
Panzyga (human normal immunoglobulin)
Suliqua (insulin glargine/lixisenatide)
Trelegy Ellipta (vilanterol/fluticasone/umeclidinium)
Vemlidy (tenofovir alafenamide fumarate)
Partner CPD from MIMS Learning
Initiated, funded and reviewed by Almirall. Date of Preparation: July 2017; UKSOY3620d
Initiated, funded and reviewed by TEVA UK. Date of Preparation: November 2017; UK/QV/17/0003
This learning module has been initiated, funded and reviewed by Edwards Lifesciences.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.